Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87


Identification and validation of PROM1 and CRTC2 mutations in lung cancer patients.

He Y, Li Y, Qiu Z, Zhou B, Shi S, Zhang K, Luo Y, Huang Q, Li W.

Mol Cancer. 2014 Jan 31;13:19. doi: 10.1186/1476-4598-13-19.


CRTC2 and PROM1 expression in non-small cell lung cancer: analysis by Western blot and immunohistochemistry.

Li Y, He Y, Qiu Z, Zhou B, Shi S, Zhang K, Luo Y, Huang Q, Li W.

Tumour Biol. 2014 Dec;35(12):11719-26. doi: 10.1007/s13277-014-2011-0. Epub 2014 Sep 26.


Genetic background and light-dependent progression of photoreceptor cell degeneration in Prominin-1 knockout mice.

Dellett M, Sasai N, Nishide K, Becker S, Papadaki V, Limb GA, Moore AT, Kondo T, Ohnuma S.

Invest Ophthalmol Vis Sci. 2014 Nov 20;56(1):164-76. doi: 10.1167/iovs.14-15479.


Homozygosity mapping and whole-genome sequencing reveals a deep intronic PROM1 mutation causing cone-rod dystrophy by pseudoexon activation.

Mayer AK, Rohrschneider K, Strom TM, Glöckle N, Kohl S, Wissinger B, Weisschuh N.

Eur J Hum Genet. 2016 Mar;24(3):459-62. doi: 10.1038/ejhg.2015.144. Epub 2015 Jul 8.


Cone-rod dystrophy and a frameshift mutation in the PROM1 gene.

Pras E, Abu A, Rotenstreich Y, Avni I, Reish O, Morad Y, Reznik-Wolf H, Pras E.

Mol Vis. 2009 Aug 28;15:1709-16.


Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation.

Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT, Poppleton H, Zakharenko S, Ellison DW, Gilbertson RJ.

Nature. 2009 Jan 29;457(7229):603-7. doi: 10.1038/nature07589. Epub 2008 Dec 17.


Whole-exome sequencing to identify novel somatic mutations in squamous cell lung cancers.

Zheng CX, Gu ZH, Han B, Zhang RX, Pan CM, Xiang Y, Rong XJ, Chen X, Li QY, Wan HY.

Int J Oncol. 2013 Sep;43(3):755-64. doi: 10.3892/ijo.2013.1991. Epub 2013 Jun 25.


The PROM1 mutation p.R373C causes an autosomal dominant bull's eye maculopathy associated with rod, rod-cone, and macular dystrophy.

Michaelides M, Gaillard MC, Escher P, Tiab L, Bedell M, Borruat FX, Barthelmes D, Carmona R, Zhang K, White E, McClements M, Robson AG, Holder GE, Bradshaw K, Hunt DM, Webster AR, Moore AT, Schorderet DF, Munier FL.

Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4771-80. doi: 10.1167/iovs.09-4561. Epub 2010 Apr 14.


Autosomal recessive retinitis pigmentosa with early macular affectation caused by premature truncation in PROM1.

Permanyer J, Navarro R, Friedman J, Pomares E, Castro-Navarro J, Marfany G, Swaroop A, Gonzàlez-Duarte R.

Invest Ophthalmol Vis Sci. 2010 May;51(5):2656-63. doi: 10.1167/iovs.09-4857. Epub 2009 Dec 30.


Comparative genomics on PROM1 gene encoding stem cell marker CD133.

Katoh Y, Katoh M.

Int J Mol Med. 2007 Jun;19(6):967-70.


Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomas.

Holmberg Olausson K, Maire CL, Haidar S, Ling J, Learner E, Nistér M, Ligon KL.

PLoS One. 2014 Sep 3;9(9):e106694. doi: 10.1371/journal.pone.0106694. eCollection 2014.


Extended extraocular phenotype of PROM1 mutation in kindreds with known autosomal dominant macular dystrophy.

Arrigoni FI, Matarin M, Thompson PJ, Michaelides M, McClements ME, Redmond E, Clarke L, Ellins E, Mohamed S, Pavord I, Klein N, Hunt DM, Moore AT, Halcox J, Sisodiya SM.

Eur J Hum Genet. 2011 Feb;19(2):131-7. doi: 10.1038/ejhg.2010.147. Epub 2010 Sep 22. Erratum in: Eur J Hum Genet. 2011 Sep;19(9):1018. Klein, Nigel [added].


Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays.

Kenmotsu H, Serizawa M, Koh Y, Isaka M, Takahashi T, Taira T, Ono A, Maniwa T, Takahashi S, Mori K, Endo M, Abe M, Hayashi I, Nakajima T, Ohde Y, Yamamoto N.

BMC Cancer. 2014 Oct 28;14:786. doi: 10.1186/1471-2407-14-786.


Severe retinitis pigmentosa mapped to 4p15 and associated with a novel mutation in the PROM1 gene.

Zhang Q, Zulfiqar F, Xiao X, Riazuddin SA, Ahmad Z, Caruso R, MacDonald I, Sieving P, Riazuddin S, Hejtmancik JF.

Hum Genet. 2007 Nov;122(3-4):293-9. Epub 2007 Jun 29.


Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.

Vachtenheim J, Horáková I, Novotná H, Opáalka P, Roubková H.

Clin Cancer Res. 1995 Mar;1(3):359-65.


Expression of a single prominin homolog in the embryo of the model chordate Ciona intestinalis.

Russo MT, Racioppi C, Zanetti L, Ristoratore F.

Gene Expr Patterns. 2014 May;15(1):38-45. doi: 10.1016/j.gep.2014.04.001. Epub 2014 Apr 19.


Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins.

Vatan O, Bilaloglu R, Tunca B, Cecener G, Gebitekin C, Egeli U, Yakut T, Urer N.

Tumori. 2007 Sep-Oct;93(5):473-7.


Association between p53 mutation and clinicopathological features of non-small cell lung cancer.

Guang SG, Ogura T, Sekine I, Yokozaki M, Esumi H, Kodama T, Nagai K.

Jpn J Clin Oncol. 1997 Aug;27(4):211-5.


Pediatric Cone-Rod Dystrophy with High Myopia and Nystagmus Suggests Recessive PROM1 Mutations.

Khan AO, Bolz HJ.

Ophthalmic Genet. 2015;36(4):349-52. doi: 10.3109/13816810.2014.886266. Epub 2014 Feb 18.


Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine.

Snippert HJ, van Es JH, van den Born M, Begthel H, Stange DE, Barker N, Clevers H.

Gastroenterology. 2009 Jun;136(7):2187-2194.e1. doi: 10.1053/j.gastro.2009.03.002. Epub 2009 Mar 24.


Supplemental Content

Support Center